Aarey Drugs and Pharmaceuticals last traded at ₹104.30 (2026-10-13). Over the past month the stock moved +9.3%, three months the stock moved +31.2%, year the stock moved +38.5%. Its closing range over 52 weeks is ₹54.07 – ₹108.05, with the latest close 3.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse industrial applications[1]
Business Overview:[1] ADPL does manufacturing of active pharmaceutical ingredients, intermediates, specialty chemicals, and trading of industrial solvents & chemicals. It caters to pharmaceuticals formulation manufacturers and pharmaceutical merchant exports.
In the latest quarter (Jun 2026), Aarey Drugs and Pharmaceuticals reported sales of ₹44.63 crore (-56.3%) and net profit of ₹1.02 crore (-25.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 44.63 | 1.32 | 2.96 | 1.02 | 0.36 |
| Mar 2026 | 189.47 | 4.34 | 2.29 | 1.56 | 0.55 |
| Dec 2025 | 96.43 | -1.51 | -1.57 | 0.57 | 0.20 |
| Sep 2025 | 84.16 | 2.64 | 3.14 | 1.02 | 0.36 |
| Jun 2025 | 102.21 | 1.71 | 1.67 | 1.37 | 0.48 |
| Mar 2025 | 108.10 | -4.21 | -3.89 | 0.47 | 0.17 |
| Dec 2024 | 133.79 | 2.20 | 1.64 | 0.72 | 0.25 |
| Sep 2024 | 105.14 | 3.72 | 3.54 | 1.60 | 0.57 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +81.8% | +74.9% | -48.6% | -19.5% | -20.0% | -27.9% | +75.3% | -56.3% |
| Operating profit growth | +102.2% | -18.5% | – | +44.9% | -29.0% | -168.6% | – | -22.8% |
| Net profit growth | +30.1% | -29.4% | -78.1% | +10.5% | -36.3% | -20.8% | +231.9% | -25.5% |
| EPS growth | +18.8% | -37.5% | -77.9% | +9.1% | -36.8% | -20.0% | +223.5% | -25.0% |
| OPM % | 3.5% | 1.6% | -3.9% | 1.7% | 3.1% | -1.6% | 2.3% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Aarey Drugs and Pharmaceuticals reported sales of ₹472.00 crore (-0.4%) and net profit of ₹4.00 crore (+0.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 472.00 | 7.00 | 2.00 | 4.00 | 1.40 |
| Mar 2025 | 474.00 | 2.00 | 0.00 | 4.00 | 1.42 |
| Mar 2024 | 396.00 | 4.00 | 1.00 | 5.00 | 1.67 |
| Mar 2023 | 419.00 | 8.00 | 2.00 | 4.00 | 1.49 |
| Mar 2022 | 493.00 | 11.00 | 2.00 | 7.00 | 2.58 |
| Mar 2021 | 348.00 | 5.00 | 1.00 | 7.00 | 2.78 |
| Mar 2020 | 298.00 | 3.00 | 1.00 | 6.00 | 2.48 |
| Mar 2019 | 354.00 | 8.00 | 2.00 | 7.00 | 2.80 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +1.4% | -15.8% | +16.8% | +41.7% | -15.0% | -5.5% | +19.7% | -0.4% |
| Operating profit growth | +0.0% | -62.5% | +66.7% | +120.0% | -27.3% | -50.0% | -50.0% | +250.0% |
| Net profit growth | +16.7% | -14.3% | +16.7% | +0.0% | -42.9% | +25.0% | -20.0% | +0.0% |
| EPS growth | +6.1% | -11.4% | +12.1% | -7.2% | -42.2% | +12.1% | -15.0% | -1.4% |
| OPM % | 2.0% | 1.0% | 1.0% | 2.0% | 2.0% | 1.0% | 0.0% | 2.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Aarey Drugs and Pharmaceuticals.
Get Free AI Stock Analysis FREE →Aarey Drugs & Pharmaceuticals standalone net profit declines 25.55% in the June 2026 quarter - Business Standard
Aarey Drugs & Pharmaceuticals standalone net profit declines 25.55% in the June 2026 quarter - Business Standard
Aarey Drugs & Pharmaceuticals standalone net profit declines 25.55% in the June 2026 quarter - Business Standard
Aarey Drugs and Pharmaceuticals shares were last quoted at ₹104.30 (+0.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Aarey Drugs and Pharmaceuticals has a price-to-earnings (P/E) ratio of 68.82 and a price-to-book (P/B) ratio of 1.90. The industry P/E is 53.33.
The 52-week high of Aarey Drugs and Pharmaceuticals is ₹104.10 and the 52-week low is ₹50.40.
The market capitalisation of Aarey Drugs and Pharmaceuticals is about ₹286.83 crore.
In the latest quarter (Jun 2026), Aarey Drugs and Pharmaceuticals reported sales of ₹44.63 crore (-56.3%) and net profit of ₹1.02 crore (-25.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Aarey Drugs and Pharmaceuticals has a 3-year ROE of 3.00%, 3-year profit growth of 2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 42.79% of Aarey Drugs and Pharmaceuticals.
Aarey Drugs and Pharmaceuticals belongs to the Pharmaceuticals & Drugs sector.